Nature

NBIM, New York City Comptroller and Storebrand supported pesticide filing at Kellanova.

Indigenous rights, lobbying, grievance and redress mechanisms, and expenditure to meet nature targets among key metrics.

Resolution round-up: Biodiversity proposal withdrawn at Kellanova; NYC public pension funds pull green financing ratio proposal at Citi.

As Drax investors remain tight-lipped on latest deforestation claims, Nordic and North American firms discuss the challenges of tackling the degradation of overlooked ecosystems.

Companies will likely be assessed on risk mitigation or policies focusing on the main drivers of ocean biodiversity loss.

Novartis to put sustainability report up for advisory vote; Exxon lawsuit ‘a governance issue’ but investors remain quiet; Mirova makes third-party assurance demands.

Europeans dominate endorser list, while Brazil and Germany take top spots for target companies.

Ocean ecosystems have traditionally been a blind spot in biodiversity data. RI looks at the options for investors trying to fill in the blanks.

Some requirements outlined in draft revision reclassified as recommendations, new disclosures added on offsets.

National Biodiversity Strategy and Action Plan (NBSAP) also explores potential for biodiversity impact index and protection being incorporated into green bond standard.